Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released May 12, 2022, before the open
10-Q filed May 12, 2022, 42 days after period end · 0001564590-22-019856
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $2.31M | $120.00K | — | — |
| Net Income | -$13.86M | -$5.48M | -$3.32M | -$8.49M |
| EPS Diluted |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$0.66 |
| -$2.15 |
| -$0.10 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.